Blood test identifies most aggressive prostate cancers

A new blood test called Stockholm3 shows promise in detecting aggressive prostate cancer more effectively than the traditional PSA test. In a study involving over 12,000 men, Stockholm3 identified 90% of severe cases compared to 74% by PSA, with fewer missed serious cancers and similar rates of false positives. Researchers suggest that this more precise test could enable earlier detection and reduce unnecessary follow-up procedures, although it is not yet available for sale in the U.S.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل